• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Video

Efficacy and Safety of Combination Treatments for BCC

Author(s):

Emily Ruiz, MD, MPH, FAAD,Todd Schlesinger, MD, FAAD

Experts in dermatology discuss the efficacy and safety combining hedgehog pathway inhibitors and immunotherapy as treatment for patients with basal cell carcinoma.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Newsletter

      Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

      Subscribe Now!
      Related Videos
      Apoptosis-Based Skin Cancer Treatment Shows Promise
      Apoptosis-Based Skin Cancer Treatment Shows Promise
      Data Review of 2 doses of Sonidegib in Advanced Basal Cell Carcinoma (BOLT Trial)
      Data Review of 2 doses of Sonidegib in Advanced Basal Cell Carcinoma (BOLT Trial)
      Expert Perspectives on EVRIANCE clinical trial data
      Expert Perspectives on EVRIANCE clinical trial data
      Data Review of the Efficacy and Safety of Vismodegib in Advanced Basal Cell Carcinoma (EVRIANCE Trial)
      Data Review of the Efficacy and Safety of Vismodegib in Advanced Basal Cell Carcinoma (EVRIANCE Trial)
      Considerations for Hedgehog vs Immunotherapy in Patients with Basal Cell Carcinoma
      Considerations for Hedgehog vs Immunotherapy in Patients with Basal Cell Carcinoma
      Expert Insights Into Locally Advanced Basal Cell Carcinoma
      Expert Insights Into Locally Advanced Basal Cell Carcinoma
      Management of Newly Diagnosed Patients with Basal Cell Carcinoma (BCC)
      Management of Newly Diagnosed Patients with Basal Cell Carcinoma (BCC)
      Treatment Considerations and Management of Adverse Events when Treating BCC
      Treatment Considerations and Management of Adverse Events when Treating BCC
      Developing a Multidisciplinary Approach when Treating BCC
      Developing a Multidisciplinary Approach when Treating BCC
      Expert Perspectives in Locally Advanced Basal Cell Carcinoma (BCC) Treatment Options
      Expert Perspectives in Locally Advanced Basal Cell Carcinoma (BCC) Treatment Options
      Related Content
      32.5% Decrease in Basal Cell Carcinoma Surgeries Reported Due to COVID-19 Pandemic
      April 17th 2025

      32.5% Decrease in Basal Cell Carcinoma Surgeries Reported Due to COVID-19 Pandemic

      The Cutaneous Connection: Episode 27
      July 22nd 2021

      The Cutaneous Connection: Episode 27- Benzene Contamination Update

      Multidisciplinary Approaches to Managing Challenging Basal and Squamous Cell Carcinomas
      March 20th 2025

      Multidisciplinary Approaches to Managing Challenging Basal and Squamous Cell Carcinomas

      The Cutaneous Connection
      May 27th 2021

      The Cutaneous Connection: Episode 24- Benzene Found in Multiple Sunscreen Products

      Aaron Farberg, MD: Image Guided SRT Achieves High Cure Rates in Non Melanoma Skin Cancer
      September 24th 2024

      Aaron Farberg, MD: Image Guided SRT Achieves High Cure Rates in Non Melanoma Skin Cancer

      Q&A: Jeffrey Stricker, DO, MBA, Discusses Study on Image-Guided SRT in Non-Melanoma Skin Cancers
      September 4th 2024

      Q&A: Jeffrey Stricker, DO, MBA, Discusses Study on Image-Guided SRT in Non-Melanoma Skin Cancers

      © 2025 MJH Life Sciences

      All rights reserved.